SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-008111
Filing Date
2020-01-29
Accepted
2020-01-29 16:44:21
Documents
4
Period of Report
2020-01-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm205897-2_8k.htm 8-K 20088
2 EXHIBIT 99.1 tm205897d2_ex99-1.htm EX-99.1 9102
3 EXHIBIT 99.2 tm205897d2_ex99-2.htm EX-99.2 23270
4 GRAPHIC tm205897d2_ex99-2img001.jpg GRAPHIC 53378
  Complete submission text file 0001104659-20-008111.txt   127365
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33451 | Film No.: 20558775
SIC: 2834 Pharmaceutical Preparations